Neal Shore, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Genesis Care
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Cold Genesys
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Urogen
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Phosphorus
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Pacific Edge
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Exact Sciences
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Sesen Bio
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Sanofi Genzyme
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Propella
    Date added:
    Date updated:
    10/12/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Nymox
    Date added:
    Date updated:
    10/12/2025

Pages

Return to Operationalizing Checkpoint Inhibitors in Urologic Practice Webcast (2022)